EHC Encompass Health Corporation

133.65USD+1.04%Mkt Cap: 13.11B USDP/E: 21.38

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis …

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap13.11B USD
Enterprise Value16.59B USD
Revenue (TTM)6.34B USD
Gross Profit5.68B USD
Net Income (TTM)566.20M USD
Revenue/Share63.88 USD
Last Price133.65 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees29.9K
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)21.38
P/E (Forward)19.41
PEG0.41
EV/EBITDA10.90
EV/Revenue2.62
P/S2.07
P/B4.90
EPS (TTM)6.25 USD
EPS (Forward)6.89 USD
52W Range
92.7780% of range143.90
52W High143.90 USD
52W Low92.77 USD
Profitability
Gross Margin95.71%
Oper. Margin18.37%
EBITDA Margin24.00%
Profit Margin9.54%
ROE23.22%
ROA7.99%
ROIC14.19%
ROCE16.84%
Growth
Revenue Growth8.90%
Earnings Growth21.60%
Cash Flow & Leverage
Operating CF1.18B USD
CapEx (TTM)736.40M USD
FCF Margin4.19%
FCF Yield2.03%
Net Debt2.73B USD
Net Debt/EBITDA1.79
Net Debt/FCF10.26
Balance Sheet
Debt/Equity1.11
Current Ratio1.09
Quick Ratio0.85
Book Value/Sh27.28 USD
Cash/Share0.78 USD
Dividends
Fwd Div Rate0.84 USD
Trail. Div Rate0.78 USD
Div. Yield0.64%
5Y Avg Yield0.84%
Payout Ratio12.48%
Ex-Div DateJan 4, 2027
Pay DateJan 15, 2027
Splits
Last Split1257:1000
Split DateJul 1, 2022
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)156.08 USD
Upside (mean)+16.8%
Target Range142.00 USD – 177.00 USD
142.00+16.8% to mean177.00
# Analysts12
Ownership
Shares Out.98.12M
Float97.15M
Insiders0.87%
Institutions103.09%
Short Interest
Short Ratio3.2d
Short % Float4.16%
Short % Out.3.68%
Shares Short3.61M
Short (prev mo.)3.49M
Technical
SMA 50127.69 (+4.7%)
SMA 200112.80 (+18.5%)
Beta0.67
S&P 52W Chg12.00%
Avg Vol (30d)1.11M
Avg Vol (10d)927.58K
Technical Indicators
RSI (14)49.9
MACD2.6165
MACD Signal3.7462
MACD Hist.-1.1297
BB Upper149.07 USD
BB Middle135.77 USD
BB Lower122.48 USD
BB Width19.58%
ATR (14)3.691 USD
Vol Ratio (20d)0.84x

About Encompass Health (NYSE: EHC)

›

Encompass Health (NYSE: EHC) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 29,875 employees.

The shares were at 133.65 USD on 20 November 2026, up 19.8% over 52 weeks. Its 52-week range is 92.77 USD to 143.90 USD: the price is 7.1% below the high and 44.1% above the low.

At a market capitalisation of 13.11B USD, it trades at 21.4 times trailing earnings and 19.4 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.8, a discount of 10% for EHC. It pays a dividend yielding 0.64% (it pays out 12% of its earnings), against a median of 0.84% among the dividend payers in that peer group.

Encompass Health reports return on equity of 23.2%, an operating margin of 18.4% and revenue up 8.9% year over year.

Its debt exceeds its cash by 2.73B USD, a debt-to-equity ratio of 1.11. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 12 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 156.08 USD is 16.8% above the current price. The next earnings report is expected on 4 February 2027.